1.Degala, et al. United States Patent 9,078,934. July 14, 2015.
2.Ostrander RV, Botte MJ, Brage ME. Efficacy of surgical preparation solutions in foot and ankle surgery. J Bone Joint Surg Am. 2005;87(5):980-985.
3.Saltzman MD, Nuber GW, Gryzlo SM, Marecek GS, Koh JL. Efficacy of surgical preparation solutions in shoulder surgery. J Bone Joint Surg Am. 2009;91:1949-1953.
4.Food and Drug Administration. FDA Drug Safety Communication: FDA requests label changes and single-use packaging for some over-the-counter topical antiseptic products to decrease risk of infection. Accessed March 19, 2019. https://www.fda.gov/drugs/drugsafety/ucm374711.htm
5.Wiemken TL. Skin antiseptics in healthcare facilities: is a targeted approach necessary? BMC Public Health. 2019;19(1):1158. doi: 10.1186/s12889-019-7507-5
6.Pyrek KM. Sterility of antiseptic products: FDA investigates, deliberates on potential recommendations. Infection Control Today. 2013:1-30. https://brnskll.com/wpcontent/uploads/2013/12/FDAinvestigates-Antiseptics-Sterility-and-potential-recommendations.pdf
7.Ostrander RV, Botte MJ, BrageME. Efficacy of surgical preparation solutions in foot and ankle surgery. J Bone Joint Surg Am. 2005;87(5):980-985.
8.Global Guidelines for the Prevention of Surgical Site Infection. Geneva: World Health Organization; 2016.Available from: https://www.ncbi.nlm.nih.gov/books/NBK401132/pdf/Bookshelf_NBK401132.pdf